 |
ferric hexacyanoferrate (II) “Prussian Blue” |
|---|---|
| Trade Name | |
| Orphan Indication | Patients with known or suspected internal contamination with radioactive or non-radioactive cesium or thallium |
| USA Market Approval | USA |
| USA Designation Date | 2003-06-26 00:00:00 |
| Sponsor | Degussa AG;Weissfrauenstr.9, D-60287;Frankfurt |
